glp-1 thibodaux Medicare's new demonstration program starts today! Learn more about it at the link in our bio! #medicare #retirement #glp1 #weightloss #turning65 GLP-1 medications get at the

Any unexplained weight loss beyond what is expected from the medication's therapeutic effect, or symptoms suggesting malabsorption such as pale, floating, foul-smelling stools, require investigation to exclude pancreatic or other gastrointestinal pathology

Inositol: Often referred to as Vitamin B8, inositol is essential for neurotransmitter signaling and has a role in fat metabolism

Monitoring: Cardiovascular: Heart rate (at regular intervals during Wegovy therapy) Gastrointestinal: For signs/symptoms of acute pancreatitis (after starting this drug) Metabolic: Blood glucose in patients with diabetes mellitus (before starting and during Wegovy therapy) Ocular: For progression of diabetic retinopathy in patients with history of diabetic retinopathy Renal: Renal function in patients with adverse reactions that could lead to volume depletion (during therapy, especially during initiation and escalation) Patient advice: Read the US FDA-approved patient labeling (Medication Guide and Instructions for Use, as applicable)

The material is supplied solely for research and analytical purposes under strictly non-clinical conditions

Tian M, Sun W, Mao Y, Zhang Y, Liu H, Tang Y